Treatment

Telephone-Based Interpersonal Therapy for PPD is Effective

Interpersonal therapy (IPT) has been shown to be effective for the treatment of postpartum depression. Typically this treatment is delivered in person; however given limited access to specialized providers, recent research has explored the [...]

By |2020-07-09T13:32:54-04:00March 19th, 2020|Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Telephone-Based Interpersonal Therapy for PPD is Effective

Internet-Based Cognitive-Behavioural Therapy for Women with PMDD

There is excellent data to support the use of selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs and SNRIs) for the treatment of premenstrual dysphoric disorder (PMDD); however, many women do not want to take [...]

By |2020-08-13T14:27:14-04:00March 5th, 2020|PMS & PMDD, Psychotherapy, Treatment|Comments Off on Internet-Based Cognitive-Behavioural Therapy for Women with PMDD

Don’t Forget About Brexanolone’s Little Sister: Zuranolone

While we have been talking about using brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant - SAGE 217 or zuranolone - has [...]

By |2026-03-10T12:50:16-04:00January 7th, 2020|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Don’t Forget About Brexanolone’s Little Sister: Zuranolone

Zulresso: Hope and lingering questions

Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new postpartum depression medication Zulresso (brexanolone) with Ob.Gyn News on August 20th, [...]

By |2021-11-22T14:52:23-04:00September 10th, 2019|Medication, ObGyn News, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Zulresso: Hope and lingering questions

Moving Forward with Brexanolone (Zulresso): Pilot Program at the Cleveland Clinic

It has been a few months since Zulresso (brexanolone), the new FDA-approved treatment for postpartum depression, has been available.  At our clinic, we have had multiple queries regarding how to obtain treatment with Zulresso. One [...]

By |2019-09-11T22:08:22-04:00September 10th, 2019|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Moving Forward with Brexanolone (Zulresso): Pilot Program at the Cleveland Clinic

CBT for Insomnia During Pregnancy: Effective but Underutilized

While we tend to think of sleep deprivation as a postpartum issue, sleep problems are relatively common during pregnancy, with 15% to 80% of women reporting sleep problems during the first trimester and 66% to [...]

By |2019-09-03T12:20:11-04:00September 3rd, 2019|Psychiatric Disorders During Pregnancy, Psychotherapy, Sleep Disorders, Treatment|Comments Off on CBT for Insomnia During Pregnancy: Effective but Underutilized

Bioidentical, Compounded Hormones Commonly Used by Perimenopausal Women, But No Consistency

Increasing numbers of peri- and post-menopausal women request “bioidentical” rather than synthetic hormones.  Although there is a tendency to think of bioidentical hormones as “all-natural”, they, like synthetic hormones, are manufactured in the laboratory.  In [...]

By |2021-11-04T08:20:41-04:00July 29th, 2019|Hormone Therapy, Menopausal Symptoms, Treatment|Comments Off on Bioidentical, Compounded Hormones Commonly Used by Perimenopausal Women, But No Consistency
Go to Top